These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15900960)

  • 1. Obesity and its comorbidities: present and future importance on health status in Switzerland.
    Neilson A; Schneider H
    Soz Praventivmed; 2005; 50(2):78-86. PubMed ID: 15900960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic burden of obesity and its comorbidities in Switzerland.
    Schmid A; Schneider H; Golay A; Keller U
    Soz Praventivmed; 2005; 50(2):87-94. PubMed ID: 15900961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost of obesity in Canada.
    Birmingham CL; Muller JL; Palepu A; Spinelli JJ; Anis AH
    CMAJ; 1999 Feb; 160(4):483-8. PubMed ID: 10081464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost of overweight, obesity, and related complications in Switzerland 2021.
    Steinl D; Holzerny P; Ruckdäschel S; Fäh D; Pataky Z; Peterli R; Schultes B; Landolt S; Pollak T
    Front Public Health; 2024; 12():1335115. PubMed ID: 39071145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk factors attributable to obesity and overweight in Switzerland.
    Davin C; Vollenweider P; Waeber G; Paccaud F; Marques-Vidal P
    Nutr Metab Cardiovasc Dis; 2012 Nov; 22(11):952-8. PubMed ID: 21478001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The obesity epidemic as harbinger of a metabolic disorder epidemic: trends in overweight, hypercholesterolemia, and diabetes treatment in Geneva, Switzerland, 1993-2003.
    Morabia A; Costanza MC
    Am J Public Health; 2005 Apr; 95(4):632-5. PubMed ID: 15798121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The public health impact of socioeconomic status on adolescent depression and obesity.
    Goodman E; Slap GB; Huang B
    Am J Public Health; 2003 Nov; 93(11):1844-50. PubMed ID: 14600051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comorbidities in overweight children and adolescents: do we treat them effectively?
    Reinehr T; Wiegand S; Siegfried W; Keller KM; Widhalm K; l'Allemand D; Zwiauer K; Holl RW
    Int J Obes (Lond); 2013 Apr; 37(4):493-9. PubMed ID: 23147116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic burden of obesity-related chronic diseases in Mainland China.
    Zhao W; Zhai Y; Hu J; Wang J; Yang Z; Kong L; Chen C
    Obes Rev; 2008 Mar; 9 Suppl 1():62-7. PubMed ID: 18307701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity and diabetes epidemics: cancer repercussions.
    Hjartåker A; Langseth H; Weiderpass E
    Adv Exp Med Biol; 2008; 630():72-93. PubMed ID: 18637486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of Alzheimer's dementia in Germany : A projection of the possible potential of reducing selected risk factors].
    Luck T; Riedel-Heller SG
    Nervenarzt; 2016 Nov; 87(11):1194-1200. PubMed ID: 26781245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic costs of obesity and inactivity.
    Colditz GA
    Med Sci Sports Exerc; 1999 Nov; 31(11 Suppl):S663-7. PubMed ID: 10593542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantifying the impact of obesity category on major chronic diseases in Canada.
    Jiang Y; Chen Y; Manuel D; Morrison H; Mao Y; Obesity Working Group
    ScientificWorldJournal; 2007 Aug; 7():1211-21. PubMed ID: 17721642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of chronic medical conditions in Switzerland: exploring estimates validity by comparing complementary data sources.
    Zellweger U; Bopp M; Holzer BM; Djalali S; Kaplan V
    BMC Public Health; 2014 Nov; 14():1157. PubMed ID: 25377723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High rates of endometrial cancer among Pacific women in New Zealand: the role of diabetes, physical inactivity, and obesity.
    Meredith I; Sarfati D; Ikeda T; Atkinson J; Blakely T
    Cancer Causes Control; 2012 Jun; 23(6):875-85. PubMed ID: 22527165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic comorbidities associated with inflammatory bowel disease: prevalence and impact on healthcare costs in Switzerland.
    Bähler C; Schoepfer AM; Vavricka SR; Brüngger B; Reich O
    Eur J Gastroenterol Hepatol; 2017 Aug; 29(8):916-925. PubMed ID: 28471826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Juvenile obesity and comorbidity type 2 diabetes mellitus (T2 DM) in Germany: development and cost-of-illness analysis].
    Wolfenstetter SB
    Gesundheitswesen; 2006 Oct; 68(10):600-12. PubMed ID: 17099820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost of obesity: the Australian perspective.
    Segal L; Carter R; Zimmet P
    Pharmacoeconomics; 1994; 5(Suppl 1):45-52. PubMed ID: 10147249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct healthcare cost of obesity in brazil: an application of the cost-of-illness method from the perspective of the public health system in 2011.
    de Oliveira ML; Santos LM; da Silva EN
    PLoS One; 2015; 10(4):e0121160. PubMed ID: 25830909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stabilization of the prevalence of childhood obesity in Switzerland.
    Aeberli I; Henschen I; Molinari L; Zimmermann MB
    Swiss Med Wkly; 2010; 140():w13046. PubMed ID: 20349364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.